Talat Imran - 09 Sep 2021 Form 4 Insider Report for Rani Therapeutics Holdings, Inc. (RANI)

Role
Chief Executive Officer, Director
Signature
/s/ Josh Seidenfeld, Attorney-in-Fact for Talat Imran
Issuer symbol
RANI
Transactions as of
09 Sep 2021
Transactions value $
$0
Form type
4
Filing time
13 Sep 2021, 20:01:34 UTC
Previous filing
02 Aug 2021
Next filing
07 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RANI Stock Option (Right to Buy) Award $0 +725,000 $0.000000 725,000 09 Sep 2021 Class A Common Stock 725,000 $19.56 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest as follows: 25% of the shares subject to the option vests on June 14, 2022; and 1/48th of the shares subject to the option vest monthly thereafter over the following three years.